170 related articles for article (PubMed ID: 29126926)
1. AJUBA increases the cisplatin resistance through hippo pathway in cervical cancer.
Bi L; Ma F; Tian R; Zhou Y; Lan W; Song Q; Cheng X
Gene; 2018 Feb; 644():148-154. PubMed ID: 29126926
[TBL] [Abstract][Full Text] [Related]
2. Ajuba overexpression regulates mitochondrial potential and glucose uptake through YAP/Bcl-xL/GLUT1 in human gastric cancer.
Li H; Fu L; Liu B; Lin X; Dong Q; Wang E
Gene; 2019 Apr; 693():16-24. PubMed ID: 30690182
[TBL] [Abstract][Full Text] [Related]
3. miR-205 Promotes Apoptosis of Cervical Cancer Cells and Enhances Drug Sensitivity of Cisplatin by Inhibiting YAP1.
Li X; Li Y; Han Y; Dong B; Liu D; Che L; Liu Y; Wang Y
Cancer Biother Radiopharm; 2020 Jun; 35(5):338-344. PubMed ID: 32379984
[No Abstract] [Full Text] [Related]
4. NHERF1 Enhances Cisplatin Sensitivity in Human Cervical Cancer Cells.
Tao T; Yang X; Qin Q; Shi W; Wang Q; Yang Y; He J
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085111
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-7-5p Promotes Cisplatin Resistance of Cervical Cancer Cells and Modulation of Cellular Energy Homeostasis by Regulating the Expression of the PARP-1 and BCL2 Genes.
Yang F; Guo L; Cao Y; Li S; Li J; Liu M
Med Sci Monit; 2018 Sep; 24():6506-6516. PubMed ID: 30219819
[TBL] [Abstract][Full Text] [Related]
6. MALAT1 promotes cisplatin resistance in cervical cancer by activating the PI3K/AKT pathway.
Wang N; Hou MS; Zhan Y; Shen XB; Xue HY
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7653-7659. PubMed ID: 30536307
[TBL] [Abstract][Full Text] [Related]
7. Cyclin I promotes cisplatin resistance via Cdk5 activation in cervical cancer.
Li R; Liu GZ; Luo SY; Chen R; Zhang JX
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4533-41. PubMed ID: 26698249
[TBL] [Abstract][Full Text] [Related]
8. Transcriptome profiling of cervical cancer cells acquired resistance to cisplatin by deep sequencing.
Wang Y; Liu L; Chen Z
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2820-2829. PubMed ID: 31293179
[TBL] [Abstract][Full Text] [Related]
9. Probing the Effects of Retinoblastoma Binding Protein 6 (RBBP6) Knockdown on the Sensitivity of Cisplatin in Cervical Cancer Cells.
Mehta H; Ambele MA; Mokgautsi N; Moela P
Cells; 2024 Apr; 13(8):. PubMed ID: 38667315
[TBL] [Abstract][Full Text] [Related]
10. AJUBA promotes the migration and invasion of esophageal squamous cell carcinoma cells through upregulation of MMP10 and MMP13 expression.
Shi X; Chen Z; Hu X; Luo M; Sun Z; Li J; Shi S; Feng X; Zhou C; Li Z; Yang W; Li Y; Wang P; Zhou F; Gao Y; He J
Oncotarget; 2016 Jun; 7(24):36407-36418. PubMed ID: 27172796
[TBL] [Abstract][Full Text] [Related]
11. Pin1 modulates chemo-resistance by up-regulating FoxM1 and the involvements of Wnt/β-catenin signaling pathway in cervical cancer.
Wang T; Liu Z; Shi F; Wang J
Mol Cell Biochem; 2016 Feb; 413(1-2):179-87. PubMed ID: 26820938
[TBL] [Abstract][Full Text] [Related]
12. CIP2A is associated with multidrug resistance in cervical adenocarcinoma by a P-glycoprotein pathway.
Liu J; Wang M; Zhang X; Wang Q; Qi M; Hu J; Zhou Z; Zhang C; Zhang W; Zhao W; Wang X
Tumour Biol; 2016 Feb; 37(2):2673-82. PubMed ID: 26404133
[TBL] [Abstract][Full Text] [Related]
13. MiR-1284 enhances sensitivity of cervical cancer cells to cisplatin via downregulating HMGB1.
Chen J; Li G
Biomed Pharmacother; 2018 Nov; 107():997-1003. PubMed ID: 30257412
[TBL] [Abstract][Full Text] [Related]
14. Interference with endogenous EZH2 reverses the chemotherapy drug resistance in cervical cancer cells partly by up-regulating Dicer expression.
Cai L; Wang Z; Liu D
Tumour Biol; 2016 May; 37(5):6359-69. PubMed ID: 26631032
[TBL] [Abstract][Full Text] [Related]
15. Glucose-Related Protein 78 Expression and Its Effects on Cisplatin-Resistance in Cervical Cancer.
Luo C; Fan W; Jiang Y; Zhou S; Cheng W
Med Sci Monit; 2018 Apr; 24():2197-2209. PubMed ID: 29650944
[TBL] [Abstract][Full Text] [Related]
16. Ajuba Overexpression Promotes Breast Cancer Chemoresistance and Glucose Uptake through TAZ-GLUT3/Survivin Pathway.
Li X; Zhao G; Mi X; Xu T; Li X; Liu B
Biomed Res Int; 2022; 2022():3321409. PubMed ID: 35178446
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting the cytoplasmic location of HMGB1 reverses cisplatin resistance in human cervical cancer cells.
Xia J; Yu X; Song X; Li G; Mao X; Zhang Y
Mol Med Rep; 2017 Jan; 15(1):488-494. PubMed ID: 27959427
[TBL] [Abstract][Full Text] [Related]
18. Vitamin C in synergism with cisplatin induces cell death in cervical cancer cells through altered redox cycling and p53 upregulation.
Leekha A; Gurjar BS; Tyagi A; Rizvi MA; Verma AK
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2503-2514. PubMed ID: 27613187
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
[TBL] [Abstract][Full Text] [Related]
20. Dual apoptotic effect of Xrel3 c-Rel/NF-kappaB homolog in human cervical cancer cells.
Shehata M; Shehata M; Shehata F; Pater A
Cell Biol Int; 2004; 28(12):895-904. PubMed ID: 15566959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]